Pathology of Pulmonary Neoplasia Flashcards

1
Q

What is the aetiology of pulmonary neoplasia?

A

Smoking.
Air pollution.
Asbestos.
Environmental radon (radiation).
Occupational exposure (chromates, hydrocarbons, nickel).
Pulmonary fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some statistics about how smoking affects lung cancer?

A

> 85% of cancers are attributable to lung cancer.
10% of smokers get lung cancer.
Females are more susceptible.
Risk is related to consumption.
Second-hand smoke increases risk by 50-100%, and causes >25% of non-smoking lung cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the current state of tobacco consumption?

A

In some countries - increasing.
Abstinence causes the risk to decrease slowly, but genomic damage persists.
There is no safe smoking threshold.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What chemicals are found in tobacco smoke?

A

~60 recognised carcinogens.
Has effects on lung epithelium.
Affects the multi-hit theory of carcinogenesis.
Activates pro-carcinogens (predisposed by inherited polymorphisms - pro-carcinogen metabolism, nicotine addiction).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pathway of carcinogenesis in the lung periphery?

A

Bronchioloalveolar epithelial stem cells transform into atypical adenomatous hyperplasia.
This becomes adenocarcinoma in situ, which develops into invasive adenocarcinoma (and becomes invasive squamous cell carcinoma).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the pathway of carcinogenesis in the central lung airways?

A

Bronchial epithelial stem cells transform into bronchial basal cell hyperplasia.
This becomes squamous dysplasia and carcinoma in situ, which develops into invasive squamous cell carcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the different types of lung ‘tumours’?

A

Metastases to the lung (common).
Benign causes of mass lesions.
Carcinoid tumours (<5% of lung neoplasms, low grade malignancy).
Tumours of bronchial glands (rare - adenoid cystic carcinoma, mucoepidermoid carcinoma, benign adenomas).
Lymphoma.
Sarcoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the main types of lung carcinomas?

A

Adenocarcinoma (41%).
Squamous cell carcinoma (40%).
Small cell carcinoma (15%).
Large cell carcinoma (4%).

Bronchioloalveolar cell carcinoma was a subtype of adenocarcinoma but is now called adenocarcinoma in situ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the histological types of lung carcinoma?

A

~15% - SCLC.
~85% - NSCLC (adenocarcinoma, squamous cell carcinoma, large cell carcinoma, and others).
Particular types of NSCLC cannot be distinguished from one another on small biopsy samples.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the natural history of primary lung cancer?

A

Grows ‘clinically silent’ for many years.
Presents late in its natural history.
May have few, if any, signs or symptoms until the disease is very advanced.
May be found incidentally during an investigation for something unrelated.
Symptomatic lung cancer is generally fatal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What bronchial obstruction can lung cancer cause?

A

Local.

Collapse.
Endogenous lipoid pneumonia.
Infection/abscess.
Bronchiectasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What nerve damage can lung cancer cause?

A

Local.

Phrenic - diaphragmatic paralysis.
Left RLN - hoarse, bovine cough.
Brachial plexus - Pancoast tumour.
Cervical sympathetic - Horner’s syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What other local effects can lung cancer cause?

A

Pleural inflammation and malignancy.
Direct chest wall invasion.
Mediastinum - SVC, pericardium.
LN metastases - mass effect, lymphangitis carcinomatosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What distant effects can lung cancer cause?

A

Distant metastases (liver, adrenals, bone, brain, skin).
Secondary to local effects (neural and vascular).
Non-metastatic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the non-metastatic paraneoplastic effects of lung cancer?

A

Skeletal - clubbing, inflammation.
Endocrine - ACTH, SIADH, PTH, gynecomastia.
Neurological - polyneuropathy, encephalopathy, cerebellar degeneration, myasthenia.
Cutaneous - acanthosis nigricans, dermatomyositis.
Haematologic - granulocytosis, eosinophilia.
Cardiovascular - thrombophlebitis migrans.
Renal - nephrotic syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What investigations are done for lung cancer?

A

CXR.
Sputum cytology (rare).
Bronchoscopy (bronchial biopsy, brushings and washings, EBUS guided aspiration).
Trans-thoracic fine needle aspiration / core biopsy.
Pleural effusion cytology and biopsy.
CT, MRI, PET, etc.

17
Q

What are prognostic factors of lung cancer?

A

Stage of disease (adjuvant therapy).
Classification of disease.
Markers, oncogenes, gene expression.
Growth rate.
Cell proliferation.
Immune cell infiltration.

18
Q

What is the prognosis of lung cancer?

A

Generally poor.
<9.8% 5YS in Scotland.
Overall correlation with stage.

Operable lung cancer -
Stage 1 >60% 5YS.
Stage 2 ~35% 5YS.
(~10% of lung cancer patients get surgery).

19
Q

What is the 5YS% of lung cancer by histological type?

A

SCLC - 4% (MS = 9 months).
NSCLC - 10-25% (some cell types are worse).

20
Q

What gene alterations are done in lung cancer?

A

Common - inactivating TSG mutations.
Very few suitable targets for gene alteration, as there are very few addictive oncogenes.

21
Q

What is adenocarcinogenesis?

A

Oncogene addiction has key driver mutations.
KRAS, EGFR, BRAF, HER2, ALK, ROS1.
Most genes are smoking induced.

22
Q

What is gene therapy for lung cancer?

A

EGFR / BRAF / HER2 mutations.
ALK / ROS1 / NTRK / RET rearrangements.
Only a minority of people are ‘genetically simple’ with an addictive oncogenic driver.

23
Q

What predictive biomarkers are selected for therapy for lung cancer?

A

Adenocarcinoma - EGFR, KRAS, HER2, BRAF, ALK, ROS1.
Squamous cell carcinoma - little to no molecular targets. Immunotherapy (NSCLC).

24
Q

What is the cancer immune response?

A

Numerous factors determine the effectiveness of a tumour-directed immune response.
Some cancers are not immunogenic.

25
Q

How does a lung tumour evade an immune response?

A

Inhibiting immune checkpoints.
The PD1/PDL1 axis immune checkpoint in NSCLCs is a therapeutic target and an important biomarker.
Drugs against immune checkpoint inhibitors are gaining increased use.